Treating mild chronic hypertension with medications during pregnancy is beneficial and safe for mother and baby, according to the results of a recent study published in The New England Journal of Medicine.
The study, known as the Chronic Hypertension and Pregnancy (CHAP) consortium, comprised about 60 clinical sites from across the United States, represented the first time that evidence-based data from the US demonstrated the benefits in treating mild forms of chronic hypertension during pregnancy.
“Following the publication of these important results, the Society for Maternal Fetal Medicine responded quickly by shifting clinical guidance to more proactively treat patients who come into their pregnancies with chronic hypertension,” noted Preeclampsia Foundation CEO Eleni Tsigas. “The Preeclampsia Foundation strongly supports this clinical guidance which significantly expands the tools at hand to prevent adverse outcomes associated with hypertension in pregnancy.”
Tsigas sat down with one of the study’s principal investigators, Dr. Alan Tita of the University of Alabama Birmingham, and Dr. Judette Louis of the Society of Maternal Fetal Medicine in a recent video interview to help patients go “Beyond the Headlines” on the study to understand what it meant for changes in patient care. | 
No comments:
Post a Comment